XML 21 R11.htm IDEA: XBRL DOCUMENT v3.25.2
Discontinued Operations and Disposal Groups
 6 Months Ended
Jun. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure Discontinued Operations
In November 2024, we sold our tissue operations. The results of our tissue operations were classified as discontinued operations in our Consolidated Statements of Operations for all periods presented. Amounts included below, for the quarter and six months ended June 30, 2025, consist of the settlement of contractual and employment related obligations that are directly related to the disposal. The following table presents the financial results of the tissue segment for the quarter and six months ended June 30, 2025 and 2024:
 Quarter Ended June 30,Six Months Ended June 30,
2025202420252024
Net sales$— $252.8 $— $505.9 
Cost of sales0.4 201.0 0.9 399.0 
Selling, general and administrative expenses0.2 7.7 0.3 15.7 
Depreciation and amortization— 14.4 — 28.2 
Other operating charges, net0.5 2.5 1.5 4.4 
Income (loss) from discontinued operations(1.2)27.3 (2.6)58.6 
Other non-operating expense— (6.4)— (11.7)
   Total non-operating expense— (6.4)— (11.7)
Income (loss) from discontinued operations before income taxes(1.2)20.9 (2.6)46.8 
Income tax benefit (provision)0.3 (5.1)1.4 (11.8)
Income (loss) from discontinued operations, net of tax$(0.9)$15.7 $(1.3)$35.0 
The major components of “Other operating charges, net” included in discontinued operations for the quarter and six months ended June 30, 2025 and 2024 are reflected in the table below.
Quarter Ended June 30,Six Months Ended June 30,
2025202420252024
Divestiture related costs$0.5 $2.5 $1.5 $4.2 
Loss on sale or impairment associated with assets— — — 0.2 
$0.5 $2.5 $1.5 $4.4 

Operating and investing cash flows of the discontinued operation are presented in the following table:
 Six Months Ended June 30,
20252024
Net cash provided by (used in) operating activities of discontinued operations$(2.0)$103.1 
Net cash used in investing activities of discontinued operations— (5.9)
Additionally, we have not finalized the working capital adjustment with the buyer and therefore have accrued an estimate in "Accounts payable and accrued liabilities" included on our Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024. Included in "Accounts payable and accrued liabilities" on our Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 was $19.2 million and $0.5 million associated with cash collected under the transition services agreement which will be remitted during the third quarter of 2025